Elliott Crouser MD
Critical Care Medicine, Pleural Disease
Associate Professor, Internal Medicine, Ohio State University College of Medicine
Join to view full profile
2050 Kenny RdPavilion Ste 2200Columbus, OH 43221
Phone+1 614-293-4925
Fax+1 614-293-5503
Dr. Crouser is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Elliott Crouser is a pulmonologist in Columbus, OH and is affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute. He received his medical degree from University of Toledo College of Medicine and has been in practice 28 years. He specializes in critical care medicine and pulmonary disease.
Education & Training
Ohio State University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1992 - 1995- Ohio State University HospitalResidency, Internal Medicine, 1989 - 1992
The University of Toledo College of MedicineClass of 1989
Certifications & Licensure
OH State Medical License 1992 - 2027
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
Publications & Presentations
PubMed
- Pragmatic approaches to improve the care of patients with sarcoidosis.Elliott D Crouser, John Odackal, Marjolein Drent
Current Opinion in Pulmonary Medicine. 2026-09-01 - Molecular characterisation of progressive pulmonary sarcoidosis: protocol for a longitudinal multi-centre study to develop peripheral blood circulating biomarkers for ...Maneesh Bhargava, Elliott D Crouser, Briana Q Barkes, Danielle O Weise, David M Perlman
BMJ Open. 2026-04-29 - 6 citationsA paradigm shift in corticosteroid therapy for sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper, endorsed by the Americ...Athol U Wells, Elyse E Lower, Robert P Baughman, Daniel A Culver, Marc A Judson
The Lancet. Respiratory Medicine. 2026-04-01
Press Mentions
aTyr Pharma Announces Expansion of Research Collaboration with the Ohio State UniversityAugust 10th, 2021- aTyr Pharma Announces Expansion of Research Collaboration with the Ohio State UniversityAugust 10th, 2021
- MedTips: Awards and AnnouncementsMarch 17th, 2021
Grant Support
- Molecular Characterization of Progressive Pulmonary SarcoidosisNATIONAL JEWISH HEALTH2023–2027
- Redox Regulation of Sarcoidosis Granulomas and FibrosisOHIO STATE UNIVERSITY2024–2026
- Supplemental Citicoline Administration for Reduction of Lung Injury Efficacy Trial (SCARLET)OHIO STATE UNIVERSITY2022–2026
- Supplemental Citicoline Administration for Reduction of Lung Injury Efficacy Trial (SCARLET)OHIO STATE UNIVERSITY2022–2026
- Role of Renin-Angiotensin-Aldosterone System during sarcoidosis granuloma formationOHIO STATE UNIVERSITY2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
